Asep Medical Holdings Inc (ASEP.CN)
CAD 0.5
(25.0%)
CAD 0.5
(25.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 21.14 Thousand CAD | 0.0% |
| 2022 | - CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | -100.0% |
| 2019 | 61.17 Thousand CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 73.99 Thousand CAD | 250.0% |
| 2024 Q2 | 73.99 Thousand CAD | 0.0% |
| 2023 Q2 | - CAD | 0.0% |
| 2023 FY | 21.14 Thousand CAD | 0.0% |
| 2023 Q4 | 21.14 Thousand CAD | 0.0% |
| 2023 Q3 | - CAD | 0.0% |
| 2023 Q1 | - CAD | 0.0% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 Q4 | - CAD | 0.0% |
| 2022 FY | - CAD | 0.0% |
| 2022 Q3 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 FY | - CAD | -100.0% |
| 2019 FY | 61.17 Thousand CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
| BetterLife Pharma Inc. | - CAD | -Infinity% |
| BioVaxys Technology Corp. | - CAD | -Infinity% |
| ChitogenX Inc. | - CAD | -Infinity% |
| Rapid Dose Therapeutics Corp. | 1.02 Million CAD | 97.928% |
| Defence Therapeutics Inc. | - CAD | -Infinity% |
| Entheon Biomedical Corp. | 250.32 Thousand CAD | 91.555% |
| Gemina Laboratories Ltd. | - CAD | -Infinity% |
| Glow Lifetech Corp. | 43.93 Thousand CAD | 51.879% |
| Lexston Life Sciences Corp. | - CAD | -Infinity% |
| Pharmala Biotech Holdings Inc. | 532 Thousand CAD | 96.026% |
| Doseology Sciences Inc. | 98.52 Thousand CAD | 78.543% |
| MYND Life Sciences Inc. | - CAD | -Infinity% |
| Nova Mentis Life Science Corp. | 28.34 Thousand CAD | 25.422% |
| PharmaTher Holdings Ltd. | - CAD | -Infinity% |
| PreveCeutical Medical Inc. | - CAD | -Infinity% |
| Telescope Innovations Corp. | 595.39 Thousand CAD | 96.449% |